Cellectar Biosciences Company Insiders

Cellectar Biosciences Management Team Effectiveness

The company has return on total asset (ROA) of (0.7231) % which means that it has lost $0.7231 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.4542) %, meaning that it created substantial loss on money invested by shareholders. Cellectar Biosciences' management efficiency ratios could be used to measure how well Cellectar Biosciences manages its routine affairs as well as how well it operates its assets and liabilities. As of February 7, 2026, Return On Tangible Assets is expected to decline to -1.65. The current year's Return On Capital Employed is expected to grow to -3.52. At present, Cellectar Biosciences' Non Current Assets Total are projected to decrease significantly based on the last few years of reporting. The current year's Total Current Assets is expected to grow to about 29.3 M, whereas Total Assets are forecasted to decline to about 15.8 M. The current year's Common Stock Shares Outstanding is expected to grow to about 1.5 M, whereas Net Loss is projected to grow to (24.5 M). The market capitalization of Cellectar Biosciences is $12.89 Million. Cellectar Biosciences shows 3.91 percent of its outstanding shares held by insiders and 8.0 percent owned by other corporate entities. Note, that even with negative profits, if the true value of the firm is larger than the current market value, you may still be able to generate positive returns on investment in this company. Some institutional investors establish a significant position in stocks such as Cellectar Biosciences in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Cellectar Biosciences, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.

Cellectar Biosciences Workforce Comparison

Cellectar Biosciences Insider Trading History

Cellectar Biosciences Notable Stakeholders

String symbol = request.getParameter("s");

The success or failure of an entity such as Cellectar Biosciences often depends on how effective the management is. Cellectar Biosciences management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Cellectar management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Cellectar management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.

Please note, the presentation of Cellectar Biosciences' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Cellectar Biosciences' management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Cellectar Biosciences' management manipulating its earnings.

When running Cellectar Biosciences' price analysis, check to measure Cellectar Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cellectar Biosciences is operating at the current time. Most of Cellectar Biosciences' value examination focuses on studying past and present price action to predict the probability of Cellectar Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cellectar Biosciences' price. Additionally, you may evaluate how the addition of Cellectar Biosciences to your portfolios can decrease your overall portfolio volatility.